验证数据展示
经过测试的应用
Positive WB detected in | EGF treated A431 cells |
Positive FC (Intra) detected in | EGF treated A431 cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
84839-1-RR targets Phospho-EGFR (Tyr869) in WB, FC (Intra), ELISA applications and shows reactivity with human samples.
经测试应用 | WB, FC (Intra), ELISA Application Description |
经测试反应性 | human |
免疫原 | Peptide 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Recombinant |
产品类型 | Antibody |
全称 | epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) |
别名 | EGFR Tyr845, EGFR (Tyr845), p-EGFR, p-EGFR (Tyr845), p-EGFR Tyr845 |
计算分子量 | 1210 aa, 134 kDa |
观测分子量 | 180 kDa |
GenBank蛋白编号 | BC094761 |
基因名称 | EGFR |
Gene ID (NCBI) | 1956 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Protein A purfication |
UNIPROT ID | P00533 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Epidermal growth factor receptor (EGFR) is a member of the receptor tyrosine kinase (RTK) family and plays a critical role in a wide variety of cellular functions, including proliferation, differentiation and apoptosis. After EGFR homodimerization with extracellular ligands such as epidermal growth factor (EGF), the intracellular tyrosine kinase domain is activated and autophosphorylates multiple tyrosine residues in the C‐terminal tail domain. (PMID: 23822636) This antibody recognizes EGFR phosphorylation at tyrosine 869, which is also widely described as the tyrosine 845 site.
实验方案
Product Specific Protocols | |
---|---|
WB protocol for Phospho-EGFR (Tyr869) antibody 84839-1-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |